Heidelberg Pharma AG (HPHA) — Cash Flow-to-Debt Ratio
Heidelberg Pharma AG (HPHA) has a Cash Flow-to-Debt Ratio of -0.13x as of May 2025, meaning its operating cash flow of €-5.53 Million could theoretically repay 0% of its total liabilities (€43.94 Million) in one year. See Heidelberg Pharma AG free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Heidelberg Pharma AG Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Heidelberg Pharma AG across 9 annual periods. Also explore Heidelberg Pharma AG (HPHA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Heidelberg Pharma AG (2016–2024)
Year-by-year debt coverage analysis for Heidelberg Pharma AG. For market capitalisation and broader financial context, see Heidelberg Pharma AG market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.99x | €-29.59 Million | €29.85 Million | ▲ +38.2% |
| 2023 | -1.60x | €-33.67 Million | €21.01 Million | ▼ -513.5% |
| 2022 | -0.26x | €-8.86 Million | €33.94 Million | ▲ +85.2% |
| 2021 | -1.77x | €-26.61 Million | €15.03 Million | ▲ +33.4% |
| 2020 | -2.66x | €-17.89 Million | €6.73 Million | ▼ -108.1% |
| 2019 | -1.28x | €-8.56 Million | €6.70 Million | ▲ +32.1% |
| 2018 | -1.88x | €-9.98 Million | €5.31 Million | ▼ -5.8% |
| 2017 | -1.78x | €-7.94 Million | €4.47 Million | ▼ -49.2% |
| 2016 | -1.19x | €-6.53 Million | €5.49 Million | — |